Euroapi S.A.

Paris Stock Exchange EAPI.PA

Euroapi S.A. EPS (Diluted) for the year ending December 31, 2023: USD -2.22

Euroapi S.A. EPS (Diluted) is USD -2.22 for the year ending December 31, 2023, a -1,195.95% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Euroapi S.A. EPS (Diluted) for the year ending December 31, 2022 was USD -0.17, a 11.54% change year over year.
Euroapi S.A. EPS (Diluted) for the year ending December 31, 2021 was USD -0.19, a -136.45% change year over year.
Euroapi S.A. EPS (Diluted) for the year ending December 31, 2020 was USD -0.08, a -374.18% change year over year.
Euroapi S.A. EPS (Diluted) for the year ending December 31, 2019 was USD 0.03.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

Paris Stock Exchange: EAPI.PA

Euroapi S.A.

CEO	Mr. Ludwig De Mot
IPO Date	May 6, 2022
Location	France
Headquarters	15 Rue Traversiere
Employees	3,650
Sector	Healthcare
Industries Pharmaceuticals Baby & Childcare Chemicals & Advanced Materials Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Plastics

Description

Euroapi SA develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. The company was incorporated in 2021 and is based in Paris, France.

Key trends

Past 5 years